Associate Director, Regulatory Affairs – CMC Small Molecules

Monte Rosa Therapeutics, Inc.; Basel; On-site; CHF 180,000 - 240,000; Full time

Job summary

Monte Rosa Therapeutics, Inc. is seeking an Associate Director of CMC Regulatory Affairs to lead global regulatory strategy for Chemistry, Manufacturing and Controls.

You will author Module 3 submissions, coordinate with Process Chemistry, Analytical Development, Drug Product, Quality, and Clinical Supply teams, and represent CMC in health authority discussions from IND/CTA through NDA/MAA. Based in Basel, this senior role requires a strong cGMP background, ICH knowledge, and a proven track

Qualifications

• Experience leading global CMC regulatory strategies across development stages.
• Authoring and review of CTD modules and summaries for regulatory submissions.
• Strong knowledge of ICH guidelines and cGMP principles.

Responsibilities

• Develop and execute global CMC regulatory strategies for small-molecule programs.
• Author and finalize Module 3 content, QOS, and responses to authorities.
• Act as primary CMC regulatory contact for programs, coordinating input from multiple teams.
• Lead risk assessments and propose mitigation plans with technical teams.
• Support health authority interactions including meetings and information requests.
• Monitor evolving CMC regulatory guidance and advise stakeholders.

Skills

CMC Regulatory Affairs

Regulatory Strategy

Regulatory Writing

Cross-functional Collaboration

Project Management

ICH Guidance Knowledge

Education

Bachelor's in Chemistry or related field

MS/PhD preferred

Tools

eCTD publishing tools

Job description

Monte Rosa Therapeutics is seeking a highly skilled and self-motivated regulatory professional to join our team as an Associate Director of CMC Regulatory Affairs. The CMC Regulatory Affairs will serve as a key regulatory strategist and author for the Chemistry, Manufacturing, and Controls components of Monte Rosa's global regulatory filings. This individual will partner closely with Process Chemistry, Analytical Development, Drug Product, Quality, and Clinical Supply teams to develop CMC regulatory strategy, author and review high-quality submission content (Module 3 and associated summaries), and represent CMC in interactions with health authorities. The role requires strong technical CMC knowledge, regulatory acumen across ICH guidelines, and the ability to operate independently in a fast-paced, growing clinical-stage environment.

• Develop and execute global CMC regulatory strategies for small-molecule molecule glue degrader drug substances and drug products across all phases of development (IND/CTA through NDA/MAA).
• Author, review, and finalize high-quality CMC regulatory submission content, including CTD Module 3 (2.3, 3.2.S, 3.2.P), Module 2.3 Quality Overall Summary, IMPD, and responses to health authority information requests.
• Serve as the primary CMC regulatory point of contact for assigned programs, coordinating cross-functional input from Process Chemistry, Analytical Development, Drug Product, Formulation, Quality Assurance, Quality Control, and CDMO/CMO partners.
• Lead CMC regulatory risk assessments, identify potential gaps or issues in manufacturing and control strategies, and propose mitigation plans in collaboration with technical teams.
• Support health authority interactions (FDA, EMA, and other global regulators) related to CMC, including pre-IND meetings, Type B/C meetings, and responses to information requests, deficiency letters, and clinical holds.
• Monitor and interpret evolving global CMC regulatory guidance and requirements and advise internal stakeholders on implications for Monte Rosa's programs.
• Contribute to the development and maintenance of internal CMC regulatory SOPs, templates, and best practices as the company scales toward late-stage development and commercialization.
• Bachelor's degree in Chemistry, Pharmaceutical Sciences, or a related scientific discipline; advanced degree (M.S. or Ph.D.) preferred.
• Minimum 8 years of progressive experience in CMC Regulatory Affairs within the biotechnology or pharmaceutical industry, including direct authorship of Module 3 content for small-molecule programs.
• Demonstrated experience preparing and/or supporting IND/CTA submissions, and direct involvement in at least one NDA/MAA or BLA CMC submission is highly desirable.
• Strong working knowledge of ICH guidelines, FDA and EMA CMC regulatory requirements, and current Good Manufacturing Practice (cGMP) principles.
• Experience collaborating with CDMOs/CMOs and cross-functional technical development teams (process chemistry, analytical, drug product) in an outsourced manufacturing model.
• Excellent scientific writing, document review, and communication skills, with the ability to translate complex technical data into clear regulatory narrative.
• Strong project management skills with the ability to manage multiple submissions and competing timelines in a fast-paced, resource-conscious environment.
• Experience with electronic submission publishing tools and eCTD structure and lifecycle management